Choi, Sung-Eun
Lee, Soo Bin
Pyo, Jung Yoon
Ahn, Sung Soo
Song, Jason Jungsik
Park, Yong-Beom
Lim, Beom Jin
Lee, Sang-Won
Funding for this research was provided by:
Korean Government (NRF-2019R1F1A1058877)
CELLTRION PHARM, Inc (NCR 2019-6)
Chong Kun Dang Pharmaceutical Corp
Article History
Received: 20 March 2023
Accepted: 31 August 2023
First Online: 8 September 2023
Competing interests
: The authors declare no competing interests.